Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.35 GBX
-1.47%
Updated:
May 6, 2024
Fusion Antibodies PLC
Cash from Financing Activities
|
Fusion Antibodies PLC
Cash from Financing Activities Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Cash from Financing Activities
£1.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Cash from Financing Activities
£64.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Cash from Financing Activities
-£1.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Cash from Financing Activities
-£191k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Cash from Financing Activities
-£2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Cash from Financing Activities
-£3.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
See Also
What is Fusion Antibodies PLC's Cash from Financing Activities?
Cash from Financing Activities
1.4m
GBP
1.4m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Cash from Financing Activities amounts to 1.4m GBP.
What is Fusion Antibodies PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-21%
-21%
Over the last year, the Cash from Financing Activities growth was 562%. The average annual Cash from Financing Activities growth rates for Fusion Antibodies PLC have been -19% over the past three years , -21% over the past five years .
You don't have any saved screeners yet
